Recent breakthroughs in HIV prevention research have created unprecedented opportunities to curb new HIV infections, save lives and set the world on a path towards eliminating HIV transmission.
Achieving the End
Key Strategies for Closing Gaps in the HIV Treatment U=U Cascade
From the AVAC Report 2012, this infographic highlights an AVAC 2013 priority of articulating and funding a retention science agenda that narrows the gaps in the Treatment U=U cascade.
Cumulative number of male circumcisions performed from 2008 to 2011
From AVAC Report 2012, this graph shows the cumulative number of male circumcisions performed from 2008 to 2011.
Non-Surgical Devices for VMMC
Pictured here, from AVAC Report 2012, is the PrePex device and Shang Ring, two non-surgical devices in development for VMMC.
Plans and Missing Pieces in PrEP Demonstration Projects: USA
This infographic from AVAC Report 2012 identifies the design and key questions for ongoing or planned PrEP demonstration projects in the US.
The Geography of Microbicide Research in sub-Saharan Africa
This map from AVAC Report 2012 spotlights the countries hosting ring and gel microbicide trials in sub-Saharan Africa.
People Not Receiving Antiretroviral and Treatment U=U and Services in One Year through Bilateral FY 2013 Sequestration
This graphic from AVAC Report 2012 illustrates the potential effects of US federal budget sequestration on HIV prevention and Treatment U=U implementation in 2013.
Follow-on trials based on RV144: Strategy includes development and research tracks
This graphic from AVAC Report 2012 shows several planned vaccine trials building on the results of the RV144 AIDS vaccine trial.
Neutralizing Antibodies: Research pathways in 2013 and beyond
There are multiple lines of inquiry stemming from the discovery of potent, broadly neutralizing antibodies that have been isolated from HIV-infected individuals. This graphic from AVAC Report 2012 presents two pathways exploring the use of BNAbs as an HIV prevention tool.